University Hospital Brno, Clinic of Internal Medicine - Hematology and Oncology

Brno 62500

2 studies enrolling now · 4 studies all time

What they study most

DLBCL Transformed From Indolent Lymphoma, Diffuse Large B-cell Lymphoma, Follicular Grade 3 Lymphoma, MF, Myelodysplastic Syndromes, Myelofibrosis, Post-ET Myelofibrosis, Post-PV MF, Primary Myelofibrosis, RRMM, de Novo DLBCL

Studies at this site

• A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions — Recruiting now
• Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib — Recruiting now
• A PK, Safety and Tolerability Study of Peripheral and Central Infusion of Melflufen in RRMM Patients — Stopped early
• Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant — Completed